174 related articles for article (PubMed ID: 35551039)
41. Synthesis, anticancer activity and molecular docking studies on 1,2-diarylbenzimidazole analogues as anti-tubulin agents.
Zhang YL; Yang R; Xia LY; Man RJ; Chu YC; Jiang AQ; Wang ZC; Zhu HL
Bioorg Chem; 2019 Nov; 92():103219. PubMed ID: 31476616
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and evaluation of new 2-chloro-4-aminopyrimidine and 2,6-dimethyl-4-aminopyrimidine derivatives as tubulin polymerization inhibitors.
Xu S; An B; Li Y; Luo X; Li X; Jia X
Bioorg Med Chem Lett; 2018 Jun; 28(10):1769-1775. PubMed ID: 29673981
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and Biological Evaluations of 1,2-Diaryl Pyrroles as Analogues of Combretastatin A-4.
Sun J; Chen L; Liu C; Wang Z; Zuo D; Pan J; Qi H; Bao K; Wu Y; Zhang W
Chem Biol Drug Des; 2015 Dec; 86(6):1541-7. PubMed ID: 26202587
[TBL] [Abstract][Full Text] [Related]
44. Microtubule inhibitors containing immunostimulatory agents promote cancer immunochemotherapy by inhibiting tubulin polymerization and tryptophan-2,3-dioxygenase.
Hua S; Chen F; Gou S
Eur J Med Chem; 2020 Feb; 187():111949. PubMed ID: 31830637
[TBL] [Abstract][Full Text] [Related]
45. Synthesis and biological evaluation of imidazo[2,1-b][1,3,4]thiadiazole-linked oxindoles as potent tubulin polymerization inhibitors.
Kamal A; Rao MP; Das P; Swapna P; Polepalli S; Nimbarte VD; Mullagiri K; Kovvuri J; Jain N
ChemMedChem; 2014 Jul; 9(7):1463-75. PubMed ID: 24715721
[TBL] [Abstract][Full Text] [Related]
46. Design, synthesis and biological evaluation of a novel tubulin inhibitor 7a3 targeting the colchicine binding site.
Lai Q; Wang Y; Wang R; Lai W; Tang L; Tao Y; Liu Y; Zhang R; Huang L; Xiang H; Zeng S; Gou L; Chen H; Yao Y; Yang J
Eur J Med Chem; 2018 Aug; 156():162-179. PubMed ID: 30006162
[TBL] [Abstract][Full Text] [Related]
47. Synthesis of benzo[d]imidazo[2,1-b]thiazole-chalcone conjugates as microtubule targeting and apoptosis inducing agents.
Sultana F; Reddy Bonam S; Reddy VG; Nayak VL; Akunuri R; Rani Routhu S; Alarifi A; Halmuthur MSK; Kamal A
Bioorg Chem; 2018 Feb; 76():1-12. PubMed ID: 29102724
[TBL] [Abstract][Full Text] [Related]
48. Design, Synthesis and Antitumor Activity of Novel link-bridge and B-Ring Modified Combretastatin A-4 (CA-4) Analogues as Potent Antitubulin Agents.
Duan YT; Man RJ; Tang DJ; Yao YF; Tao XX; Yu C; Liang XY; Makawana JA; Zou MJ; Wang ZC; Zhu HL
Sci Rep; 2016 May; 6():25387. PubMed ID: 27138035
[TBL] [Abstract][Full Text] [Related]
49. Design, synthesis and biological evaluation of novel thiazole-naphthalene derivatives as potential anticancer agents and tubulin polymerisation inhibitors.
Wang G; Liu W; Fan M; He M; Li Y; Peng Z
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1694-1702. PubMed ID: 34309466
[TBL] [Abstract][Full Text] [Related]
50. Identification of gallic acid based glycoconjugates as a novel tubulin polymerization inhibitors.
Upadhyaya K; Hamidullah ; Singh K; Arun A; Shukla M; Srivastava N; Ashraf R; Sharma A; Mahar R; Shukla SK; Sarkar J; Ramachandran R; Lal J; Konwar R; Tripathi RP
Org Biomol Chem; 2016 Jan; 14(4):1338-58. PubMed ID: 26659548
[TBL] [Abstract][Full Text] [Related]
51. Synthesis, biological evaluation, and structure-activity relationships of new tubulin polymerization inhibitors based on 5-amino-1,2,4-triazole scaffold.
Yang F; Chen L; Lai JM; Jian XE; Lv DX; Yuan LL; Liu YX; Liang FT; Zheng XL; Li XL; Wei LY; You WW; Zhao PL
Bioorg Med Chem Lett; 2021 Apr; 38():127880. PubMed ID: 33636303
[TBL] [Abstract][Full Text] [Related]
52. Synthesis and bioevaluation of N-(3,4,5-trimethoxyphenyl)-1H-pyrazolo[3,4-b]pyridin-3-amines as tubulin polymerization inhibitors with anti-angiogenic effects.
Hao SY; Qi ZY; Wang S; Wang XR; Chen SW
Bioorg Med Chem; 2021 Feb; 31():115985. PubMed ID: 33421913
[TBL] [Abstract][Full Text] [Related]
53. Discovery of novel coumarin-indole derivatives as tubulin polymerization inhibitors with potent anti-gastric cancer activities.
Song J; Guan YF; Liu WB; Song CH; Tian XY; Zhu T; Fu XJ; Qi YQ; Zhang SY
Eur J Med Chem; 2022 Aug; 238():114467. PubMed ID: 35605363
[TBL] [Abstract][Full Text] [Related]
54. Design, synthesis and bioevaluation of 6-aryl-1-(3,4,5-trimethoxyphenyl)-1H-benzo[d]imidazoles as tubulin polymerization inhibitors.
Liu R; Huang M; Zhang S; Li L; Li M; Sun J; Wu L; Guan Q; Zhang W
Eur J Med Chem; 2021 Dec; 226():113826. PubMed ID: 34571171
[TBL] [Abstract][Full Text] [Related]
55. Structure modification and biological evaluation of indole-chalcone derivatives as anti-tumor agents through dual targeting tubulin and TrxR.
Yan J; Xu Y; Jin X; Zhang Q; Ouyang F; Han L; Zhan M; Li X; Liang B; Huang X
Eur J Med Chem; 2022 Jan; 227():113897. PubMed ID: 34649064
[TBL] [Abstract][Full Text] [Related]
56. A novel synthetic compound exerts effective anti-tumour activity in vivo via the inhibition of tubulin polymerisation in A549 cells.
Yan J; Pang Y; Sheng J; Wang Y; Chen J; Hu J; Huang L; Li X
Biochem Pharmacol; 2015 Sep; 97(1):51-61. PubMed ID: 26212540
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and biological evaluation of imidazo[1,5-a]pyridine-benzimidazole hybrids as inhibitors of both tubulin polymerization and PI3K/Akt pathway.
Kamal A; Rao AV; Nayak VL; Reddy NV; Swapna K; Ramakrishna G; Alvala M
Org Biomol Chem; 2014 Dec; 12(48):9864-80. PubMed ID: 25354805
[TBL] [Abstract][Full Text] [Related]
58. Novel hybrid nocodazole analogues as tubulin polymerization inhibitors and their antiproliferative activity.
Kale SS; Jedhe GS; Meshram SN; Santra MK; Hamel E; Sanjayan GJ
Bioorg Med Chem Lett; 2015 May; 25(9):1982-5. PubMed ID: 25817588
[TBL] [Abstract][Full Text] [Related]
59. Combretastatin A-4 sulfur-containing heterocyclic derivatives: Synthesis, antiproliferative activities and molecular docking studies.
Faouzi A; Arnaud A; Bancet A; Barette C; Preto J; Do CV; Jordheim LP; Bousfiha Z; Nguyen TTB; Verrière M; Farce A; Fauvarque MO; Barret R; Lomberget T
Eur J Med Chem; 2021 Apr; 215():113275. PubMed ID: 33618157
[TBL] [Abstract][Full Text] [Related]
60. The discovery of novel indazole derivatives as tubulin colchicine site binding agents that displayed potent antitumor activity both in vitro and in vivo.
Cui YJ; Ma CC; Zhang CM; Tang LQ; Liu ZP
Eur J Med Chem; 2020 Feb; 187():111968. PubMed ID: 31865012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
